Omnicell Inc
OMCLOmnicell Inc (OMCL) is a healthcare technology company that specializes in medication management solutions, including automation and robotics for hospitals, long-term care, and retail pharmacy settings. Its products and services aim to improve medication safety, operational efficiency, and clinical outcomes through automation systems, inventory management, and analytics. Founded in 1992 and headquartered in Mountain View, California, Omnicell is recognized for its innovation in healthcare automation.
Company News
As Q1 2026 earnings season begins, the article identifies 10 undervalued US stocks expected to report earnings within 10 days. These stocks appear undervalued by 36-60% based on fair value estimates, with analysts projecting potential gains of 22-117%. Three highlighted stocks are Churchill Downs (gaming/entertainment), Gentex (automotive vision ...
The global robotic pharmacy prescription market is experiencing significant growth, expanding from USD 214.16 million in 2025 to USD 237.65 million in 2026, with a projected CAGR of 9.18% through 2032, reaching USD 396.21 million. The market is driven by automation adoption for medication safety and efficiency, workforce transformation toward cli...
Omnicell's EVP & Chief Legal/Admin Officer Corey Manley sold 6,106 shares worth $243,629 on December 3, 2025, reducing his direct holdings by 5.85%. The sale occurred as the stock approached 52-week highs following strong Q3 results and the announcement of the company's new Titan XT automated dispensing system, which prompted analyst upgrades.
Evoke Pharma partnered with EVERSANA and Omnicell to expand access to GIMOTI nasal spray for gastroparesis treatment, targeting large gastroenterology practices and specialty pharmacies through strategic pharmacy network agreements.
The global pharmacy automation market is projected to grow from USD 6.99 billion in 2025 to USD 16.65 billion by 2034, driven by technological advancements, chronic disease management, and the need to reduce medication errors.
